Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SHANGHAI, July 15, 2013 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2013 after the New York Stock Exchange closes on Monday, August 12, 2013 (which will be Tuesday morning, August 13, 2013 Shanghai time). The earnings release will be available on the investor relations section of the Company’s website at http://www.wuxiapptec.com/.
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, August 13, 2013, to discuss the second-quarter 2013 financial results and recent business activities. The conference call may be accessed by calling:
Australia | 1800 801 825 |
Belgium | 0800 784 01 |
Canada | 1855 842 3490 |
China | 4001 200 539 |
France | 0800 916 599 |
Germany | 0800 1899 399 |
Hong Kong | 800 905 927 |
Hong Kong (toll) | +852 5808 3202 |
India | 000 800 100 8255 |
Indonesia | 00180 301 91840 |
Ireland | 1800 720 105 |
Italy | 800 875 577 |
Japan | 0120 271 900 |
Malaysia | 1800 816 107 |
Netherlands | 0800 0234 240 |
New Zealand | 0800 452 905 |
Singapore | 800 616 3222 |
South Korea | 00798 6136 1434 |
Sweden | 0207 968 70 |
Switzerland | 0800 837 001 |
Taiwan | 0080 161 5189 |
United Kingdom | 0800 015 9725 |
United KingdomLondon (toll) | 44 (0) 20 3078 7622 |
United States | 1855 298 3404 |
United StatesNew York (toll) | +1 631 5142 526 |
Other countries (toll) | +65 6823 2299 |
Conference ID: | 1007691 |
A telephone replay will be available two hours after the call’s completion at:
Australia | 1800 008 585 |
Belgium | 0800 11 797 |
Canada | 1866 4783 460 |
China | 4001 842 240 |
France | 0800 904 160 |
Germany | 0800 181 3763 |
Hong Kong | 800 966 697 |
India | 000 800 100 6647 |
Indonesia | 0018 0306 12086 |
Ireland | 1800 511 665 |
Italy | 800 784 706 |
Japan | 0066 3386 1031 |
Malaysia | 1800 181 061 |
Netherlands | 08000 232 153 |
New Zealand | 0800 444 310 |
Singapore | 800 616 2127 |
South Korea | 00798 612 1058 |
Sweden | 020 792 274 |
Switzerland | 0800 564 016 |
Taiwan | 00801 232 352 |
United Kingdom | 0800 169 7301 |
United States | 1866 846 0868 |
Conference ID: | 1007691 |
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech’s website at http://www.wuxiapptec.com/.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email: Ron_Aldridge@wuxiapptec.com
Web: http://www.wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
Help employers find you! Check out all the jobs and post your resume.
